Decision Aids for Tamoxifen Treatment in Breast Cancer Patients
- Conditions
- Breast Cancer
- Interventions
- Behavioral: Decision aids (tamoxifen-related educational materials in brochure or mobile app)
- Registration Number
- NCT02488603
- Lead Sponsor
- National Cancer Center, Korea
- Brief Summary
This is an educational intervention study for breast cancer patients who undergo tamoxifen treatment. The purpose of the study is to assess the impact of decision aids (DA) on the patients' decision-making process, compliance on drug, and knowledge regarding tamoxifen treatment. Patients will randomly assign to DA group or conventional group. Both groups will have baseline questionnaire surveys before starting tamoxifen treatment, and 4 weeks later follow-up questionnaire surveys.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 360
- Breast cancer patients who are recommended to undergo tamoxifen treatment in National Cancer Center, Korea
-
- Age at least 18 years and more
- Age under 18 years
- Inability to read or speak Korean
- Disagree to provide a written informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Decision aids Decision aids (tamoxifen-related educational materials in brochure or mobile app) - Decision aids tamoxifen -
- Primary Outcome Measures
Name Time Method Change in Knowledge of Tamoxifen Scale baseline, 4weeks later
- Secondary Outcome Measures
Name Time Method Decisional Conflict Scale baseline, 4weeks later Assess the decisional conflict regarding tamoxifen treatment
Satisfaction with Decision Questionnaire baseline, 4weeks later Assess the satisfaction with decision to undergo tamoxifen treatment
EORTC QLQ-C30 Questionnaire baseline, 4weeks later Assess the quality of life before and during tamoxfen treatment
EQ-5D Questionnaire baseline, 4weeks later Assess the quality of life before and during tamoxfen treatment